Two new clinical trials aimed at treating Alzheimer’s disease are starting up at Barrow Neurological Institute.
Both trials use existing drugs for two very different conditions. The first trial will look at the effects of a bone cancer drug in those living with mild cognitive impairment.
Dr. Marwan Sabbagh is a behavioral neurologist at Barrow’s Alzheimer’s and Memory Disorders Program…